← All Clover Health Investments, CORP /DE filings

Clover Health Investments, CORP /DE Form 4 insider transactions

NASDAQ
CLOV
Clover Health Investments, CORP /DE
Form 4: Clover Health Investments General Counsel Karen Soares Reports Tax-Related Stock Disposal
Karen Soares, General Counsel & Secretary of Clover Health Investments, disposed of 5,168 shares of Class A Common Stock on March 15, 2024, to cover tax obligations related to vesting restricted stock units.
NASDAQ
CLOV
Clover Health Investments, CORP /DE
Form 4: Clover Health Executive Wai Conrad Disposes of Shares to Cover Tax Obligations
Clover Health's Chief Technology Officer, Conrad Wai, disposed of shares to cover tax obligations arising from the vesting of restricted stock units.
NASDAQ
CLOV
Clover Health Investments, CORP /DE
Form 4: Clover Health CEO Jamie Reynoso Disposes of Shares for Tax Obligations
Jamie Reynoso, CEO of Medicare Advantage at Clover Health, disposed of 7,777 shares of Class A Common Stock to cover tax obligations upon the vesting of restricted stock units (RSUs).
NASDAQ
CLOV
Clover Health Investments, CORP /DE
Form 4: Anna U. Loengard Increases Stake in Clover Health Investments, Corp. (CLOV)
Director Anna U. Loengard reports purchasing 137,000 shares of Clover Health Investments, Corp. at an average price of $0.73 per share.